Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting

@inproceedings{Habel2009DecliningRA,
  title={Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting},
  author={Laurel A. Habel and Ninah S. Achacoso and Reina Haque and Larissa Nekhlyudov and Suzanne W. Fletcher and Stuart J. Schnitt and Laura S. Collins and Ann M. Geiger and Balaram Puligandla and Luana Acton and Charles Patrick Quesenberry},
  booktitle={Breast Cancer Research},
  year={2009}
}
Randomized trials indicate that adjuvant radiotherapy plus tamoxifen decrease the five-year risk of recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery from about 20% to 8%. The aims of this study were to examine the use and impact of these therapies on risk of recurrence among ductal carcinoma in situ patients diagnosed and treated in the community setting. We identified 2,995 patients diagnosed with ductal carcinoma in situ between 1990 and 2001 and… CONTINUE READING